Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.

Jammbe Z MusoroS C SodergrenC CoensA PochesciM TeradaM T KingM A G SprangersM GroenvoldK CocksG VelikovaHans-Henning FlechtnerA Bottomleynull null

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2020)

These findings have clinical relevance for the interpretation of treatment efficacy and the design of clinical trials by informing sample size requirements.

Keyphrases

clinical trial
locally advanced
randomized controlled trial
phase ii
open label
rectal cancer
smoking cessation